[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Flu Vac in the Pandemic", "description": "Seasonal Influenza\n\nCaused by influenza viruses\n\nPhoto Credit: Cynthia Goldsmith Content Providers(s): CDC/ Dr. Terrence Tumpey. X 100,000\n\nCDC\n\nhttps://www.cdc.gov/flu/weekly/index.htm\n\nUK, 2020 - 2021\n\nhttps://www.england.nhs.uk/wp-content/uploads/2020/05/Letter_AnnualFlu_2020-21_20200805.pdf\n\nthe national flu immunisation programme will be absolutely essential to protecting vulnerable people\n\nand supporting the resilience of the health and care system \n\nMild to severe illness\n\nHigher viral doses, the more sick people became\n\nhttps://academic.oup.com/cid/article/60/5/693/291415\n\nOld, young, co-morbidities\n\nhttps://www.cdc.gov/flu/about/burden/index.html\n\nAnnually (US) since 2010\n\n9 million \u2013 45 million illnesses\n\n140,000 \u2013 810,000 hospitalizations\n\n12,000 \u2013 61,000 deaths\n\nhttps://www.hopkinsmedicine.org/health/conditions-and-diseases/influenza/influenza-flu-in-children\n\nClinical features in children\n\nFever, which may be as high as 103\u00b0F (39.4\u00b0C) to 105\u00b0F (40.5\u00b0C)\n\nBody aches, which may be severe\n\nHeadache\n\nSore throat\n\nCough that gets worse\n\nTiredness\n\nRunny or stuffy nose\n\nNausea\n\nVomiting\n\nDiarrhea\n\nPossible complications in children\n\nPneumonia\n\nDehydration\n\nSalts (electrolytes)\n\nWorsening of long-term medical problems\n\nBrain dysfunction such as encephalopathy\n\nSinus problems and ear infections\n\nIn rare cases, death\n\nInitial concern\n\nIncreased Risk of Noninfluenza Respiratory Virus Infections Associated With Receipt of Inactivated Influenza Vaccine (Clinical Infectious Diseases, 2012)\n\nhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404712/\n\nWe were able to observe a statistically significant increased risk of confirmed noninfluenza respiratory virus infection among TIV recipients\n\nCovid-19: Risk of death more than doubled in people who also had flu, English data show\n\nhttps://www.bmj.com/content/370/bmj.m3720\n\nOdds of death were 2.27 times higher than in people with SARS-CoV-2 alone\n\npossible synergistic effects in coinfected people\n\n\nSafety of Influenza Vaccine during COVID-19 (September 2020, Journal of Clinical and Translational Science, Cleveland Clinic)\n\nhttps://www.cambridge.org/core/journals/journal-of-clinical-and-translational-science/article/safety-of-influenza-vaccine-during-covid19/C26A417046677E65D421AD33B3E6281F\n\nThe convergence with influenza season could result in significant morbidity and mortality\n\nPatients (n = 18,868) tested for COVID-19\n\n4,138 flu vac, 2019-2020\n\n9,082 not flu vaccinated\n\nVaccinated group\n\nHigher BMI\n\nOn more meds\n\nMore co-morbidities \n\nOlder\n\nBlood work\n\nIs someone had flu vac and tested positive for SARS-CoV-2\n\nUnadjusted analysis shows:\n\nVaccinated individuals were less likely to test positive for SARS-CoV-2\n\nMore likely to be hospitalized\n\nMore likely to be admitted to the ICU and die during hospitalization\n\nBut, once adjusted\n\nInfluenza vaccination was unrelated to incidence of SARS- CoV-2 infection\n\nIncreased risk for worse hospital outcomes was not related to influenza vaccination\n\nIn people with COVID-19, influenza vaccination did not impact risk for hospitalization\n\nOr ICU admission \n\nOr hospital mortality \n\nOverall\n\nInfluenza vaccination does not increase the incidence of COVID-19\n\nor worsen the related morbidity or mortality\n\nProviding reassurance that the vaccination strategy for global influenza should proceed as planned during the COVID-19 pandemic \n\nSurveillance data needs to be prospectively collected in fall 2020\n\nStudy the outcome of concurrent SARS-CoV-2 and influenza infection\n\nAssess any interaction between influenza vaccinations, a newly developed vaccine against coronavirus, influenza and COVID-19 infection\n\nOdds of death were 2.27 times higher than in people with SARS-CoV-2 alone", "link": "https://www.youtube.com/watch?v=8-31xcWma9I", "date_published": "2020-10-14 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Pandemic in Europe and UK", "description": "UK\nCases, + 13, 972 + 17,234 = 634,920\n\nhttps://coronavirus.data.gov.uk/cases\n\nEngland, + 14,310\n\nScotland + 1,297\n\nWales, + 764\n\nNI + 863\n\nRecent increase in older people\n\nDeaths, + 143 = 43,018\n\nONS figure, 58,500 deaths\n\nHighest since 165 deaths on 10th June\n\nTracker app\n\nhttps://covid.joinzoe.com\n\nCases, + 24,611\n\nActive, 352, 880\n\n1st April, 2 million\n\nhttps://covid.joinzoe.com/data\n\nGraham Medley, London School of Hygiene and Tropical Medicine\n\n400 deaths a day by the start of November\n\nThe people who died today were infected two to three weeks ago\n\npeople who will die in two to three weeks\u2019 time are among those infected today\n\ndoubling time of infections has been about 10 days for the past month\n\nDavid J Hunter, Oxford University\n\na steady, inexorable rise in hospitalisations\n\nICU Covid bed occupancy\n\nand deaths over the last month and leave no doubt the second wave is well advanced\n\nDr David Strain, University of Exeter\n\nInfections were, first in younger adults, moving into older adults three weeks or so ago\n\nthis week is when we would have anticipated the rise in death rates to start occurring\n\nThe idea that you can mix freely with five other households is nonsense, basically\n\nONS\n\nhttps://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19roundup/2020-03-26\n\nCases, 25 September to 1 October 2020\n\n224,400 people, community population, England\n\nOne in 240 people\n\n17,200 new cases per day\n\nNumber of infections has increased rapidly in recent weeks\n\nOlder teenagers and young adults\n\nHighest rates seen in the North East, North West, Yorkshire, Humber\n\nWales, 6,100 people\n\n1 in 500 people\n\nNorthern Ireland\n\n1 in 500 people (95 % credible interval: 1 in 1,900 to 1 in 200).\n\nDeaths, 25 September to 1 October 2020\n\n4.1% (390 deaths) above the five-year average\n\n321 mentioned \u201cnovel coronavirus (COVID-19)\u201d\n\n3.2% of all deaths in England and Wales\n\nPrevious week, 215 (2.2%)\n\nWales, 12 deaths (Week 39) to 25 deaths (Week 40)\n\nUK as a whole\n\nWeek 39, 234 COVID deaths\n\nWeek 40, 343 COVID deaths\n\nOperation moon-shot\n\nwould allow people to lead more normal lives, without the need for social distancing\n\nhttps://www.theguardian.com/world/2020/oct/13/operation-moonshot-doubts-over-uk-covid-saliva-tests-plan-after-trial-scaled-back\n\nSix weeks in\n\nPilot to regularly test 254,000 people, paused last week, largely scaled back\n\nSalford in Greater Manchester\n\nRegular saliva tests\n\nAbout an hour \n\nNow be smaller in scale and focused on high-risk environments and groups\n\n250 provided regular saliva samples\n\nLack of clarity as to accuracy of saliva-based tests\n\nThree levels of COVID alert\n\nMedium, high and very high \n\nMedium level/tier one\n\nRule of six\n\nClosure of venues at 10pm\n\nFood and drink selling venues, closed between 10pm and 5am\n\nAfter 10pm food, delivery service, click-and-collect or drive-thru\n\nAll businesses and venues can continue to operate\n\nIn a Covid-secure manner\n\nNightclubs and adult entertainment venues remain closed\n\nSchools, universities\n\nWeddings and funerals can go ahead, restrictions on the number of attendees\n\nHigh level/tier two\n\nAdditional measures are in place:\n\nPeople must not meet with anybody outside their household or support bubble in any indoor setting\n\nPeople should aim to reduce the number of journeys they make\n\nWalk or cycle where possible\n\nAvoid busy times and routes on public transport\n\nVery high level/tier three\n\nAdditional measures are in place:\n\nPubs and bars must close\n\nUnless serving substantial meals\n\nMay only serve alcohol as part of such a meal\n\nWedding receptions are not allowed\n\nAvoid travelling in or out\n\nAvoid in or out overnights\n\nOther than for work, education, accessing youth services, caring \n\ntransittps://www.theguardian.com/world/2020/oct/13/operation-moonshot-doubts-over-uk-covid-saliva-tests-plan \n\nLiverpool \n\nManchester, Lancashire\n\nHospitalisations\nhttps://coronavirus.data.gov.uk/healthcare", "link": "https://www.youtube.com/watch?v=oDlNdit0hKA", "date_published": "2020-10-14 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Coronavirus survival", "description": "Survival of SARS-CoV-2 in different environmental conditions\nStability of SARS-CoV-2 in different environmental conditions (Lancet April)\n\nhttps://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(20)30003-3/fulltext\n\nSARS-CoV-2 more stable on smooth surfaces\n\nNo infectious virus could be detected from smooth surfaces on day 4 (glass and banknote)\n\nOverall, SARS-CoV-2 can be highly stable in a favourable environment\n\nSusceptible to standard disinfection methods. \n\n\nThe effect of temperature on persistence of SARS-CoV-2 on common surfaces (Virology Journal, 7th October)\n\nAustralian Centre for Disease Preparedness, Geelong, VIC, Australia\n\nhttps://virologyj.biomedcentral.com/articles/10.1186/s12985-020-01418-7\n\nThe rate at which COVID-19 has spread throughout the globe has been alarming\n\nRole of fomite transmission is not yet fully understood\n\nThe risks of fomite transmission from contaminated surfaces.\n\nThis study measured the survival rates of infectious SARS-\n\nCoV-2, on several common surface types\n\nIn the dark, (negate any effects of UV light)\n\n20\u2019C\n\nHalf-lives 1.7 to 2.7 days\n\nViral loads equivalent to the highest titres excreted by infectious patients\n\nViable virus was isolated for up to 28 days at 20 \u00b0C from common surfaces \n\nGlass\n\nStainless steel\n\nPaper and polymer banknotes\n\n40\u2019C\n\nVirus survived less than 24 h at 40 \u00b0C on some surfaces\n\nSARS-CoV-2 can remain infectious for significantly longer time periods than generally considered possible\n\nThese results could be used to inform improved risk mitigation procedures to prevent the fomite spread of COVID-19.\n\nExaggerated risk of transmission of COVID-19 by fomites (Lancet 3rd July)\n\nhttps://www.thelancet.com/pdfs/journals/laninf/PIIS1473-3099(20)30561-2.pdf\n\nIn my opinion, the chance of transmission through inanimate surfaces is very small\n\nWhere an infected person coughs or sneezes on the surface\nand someone else touches that surface soon after the cough or sneeze (within 1\u20132 h)\n\nI do not disagree with erring on the side of caution\n\nAlthough periodically disinfecting surfaces and use of gloves are reasonable precautions especially in hospitals\n\nCDC, How COVID-19 Spreads\n\nhttps://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html", "link": "https://www.youtube.com/watch?v=lUyStbhi2Xs", "date_published": "2020-10-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Pandemic learning from Japan", "description": "Japan\n\nDynamic Change of COVID-19 Seroprevalence among Asymptomatic Population in Tokyo during the Second Wave (Tokyo and Boston)\n\nhttps://www.medrxiv.org/content/10.1101/2020.09.21.20198796v1.full.pdf\n\nPopulation 127 million\n\nCases, 89,650\n\nDeaths, 1,631\n\nFatality rates, low compared to Western Countries\n\nDecreased despite the absence of lockdown \n\n? low infection prevalence\n\n? low IFR\n\nSeroprevalence among asymptomatic employees, Tokyo\n\nMay 26 to August 25\n\nHealthy volunteer workers, n = 1,877 \n\nIgM and IgG antibodies, test repeated at a month\n\nSymptomatics excluded\n\nSeroconversion\n\nSeroreversion\n\nResults\n\n615 healthy volunteers received at least one test\n \nSeroprevalence increased from 5.8 % to 46.8 % over summer\n\nParalleling the rise in daily confirmed cases within Tokyo\n\nExclusion of individuals with clinical symptoms, probable underestimation\n\nPeaked on August 4\n\nPeaked with the peak of the second wave\n\nOut of the 350 individuals who completed both offered tests\n\n21.4 % who tested seronegative became seropositive\n\nSeroreversion was found in 12.2 % of initially seropositive participants\n\n81.1% of IgM positive cases at first testing became IgM negative in approximately one month \n\nIgM+/IgG- was the least common, 0.4% (3/700 total tests)\n\nShort time frame between developing IgM then developing IgG\n\nNone of the seroconverted individuals were hospitalized or died\n\nConclusions\n\nCOVID-19 infection may have spread widely across the general population of Tokyo\n\nDespite the very low fatality rate\n\nTemporal correlation between the rise in seropositivity and the decrease in reported COVID-19 cases\n\nHow to explain?\n\nLocal observations\n\nMasks culture\n\nNon-tactile culture\n\nQuite culture\n\nVentilation culture\n\nApp use\n\nLimited international travel\n\nSupervised quarantine, 14 days\n\nDiet\n\nWhy Is the Obesity Rate So Low in Japan and High in the U.S.? (Research Gate)\n\nhttps://www.researchgate.net/publication/23519385_Why_Is_the_Obesity_Rate_So_Low_in_Japan_and_High_in_the_US_Some_Possible_Economic_Explanations\n\nBMI over 30, international standard for obesity\n\nJapan, 3.6%\n\nUS, 32.0%\n\nBMI over 25, overweight\n\nJapan, 24.7%\n\nUS, 66.5%\n\nThe average person in Japan consumes over 200 fewer calories per day than the average American\n\nDrive less, walk more, use more public transport", "link": "https://www.youtube.com/watch?v=NQ1h33mPGuU", "date_published": "2020-10-13 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]